DEXILANT
HIKMA
Identification
- Active ingredient (INN)
- DEXLASOPRAZOLE
- Internal code
- 10 A 215
- Country of Origin
- Algeria
- Pharmaceutical form
- Delayed-release Capsule
- Prescription List
- Regulated (List II)
- Packaging
- b/14
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Used to treat corrosive esophagus and visible intestinal carrot disease by reducing the production of stomach acids.
Associated Conditions
Before using this drug, your doctor or pharmacist told you about medical history, especially from liver diseases.
Some symptoms may actually be more serious.
Get immediate medical assistance if you have: burn with dizziness/dorning/doring/ shoulder pain (especially with limited breathing and unusual sweating), and loss of unprovoked weight.
Proton pumps may increase the risk of bone fractures, especially with long use, at higher doses, and at older adults.
Talk to your doctor or pharmacist about ways to prevent loss of bone/fruit, such as taking calcium (such as calcium vests) and vitamin D supplements, and to treat breasts, and to treat any drugs that are not used.
Mechanism of Action
It reduces the symptoms of stomach burn, the difficulty of swallowing, and constant coughing, it helps to reduce damage from stomach acids and helps prevent ulcers, and it can help prevent ulcer cancer.
Dexlansoprazole belongs to a group of drugs known as proton pump inhibitors.